Both in Pharmaceuticals
Climb Bio vs Neurogene
Over the past year CLYM returned +386.5% and NGNE returned −1.9%; their daily moves had a correlation of 0.26.
CLYM +386.5% NGNE −1.9%Growth of $1, one year, split-adjusted
| Metric | CLYM | NGNE |
|---|---|---|
| Price | $10.12 | $30.42 |
| Market cap | $581.3M | $608.7M |
| Today | +5.75% | +12.71% |
| 1 month | −12.0% | +7.2% |
| 6 months | +15.3% | +14.9% |
| Year to date | +153.0% | +47.7% |
| 1 year | +381.9% | −5.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $183.1M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 75.7% |
| Short % of float | 25.6% | 39.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).